New protein offers hope to AMD sufferers

Article

A protein, called Robo4, has been identified which appears to play an important role in the development of stable, working blood vessels.

A protein, called Robo4, has been identified which appears to play an important role in the development of stable, working blood vessels, reports a study published online ahead of print by Nature Medicine.

Dean Y Li and colleagues from the University of Utah activated the proteins in mice bred to mimic the effects of age-related macular degeneration (AMD) and diabetic retinopathy (DR) and found that blood vessel damage was prevented and, in some cases, even reversed.

Although this does not yet prove that the same principle will work in humans, the researchers believe that it does represent a major breakthrough, which could be harnessed to produce important drugs.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.